Friday, 24 May 2019

Pharma News

  • NIH study: Diabetes drug Metformin extends life

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 31 Jul, 2013

    Singapore: Long-term treatment with the type 2 diabetes drug metformin improves health and longevity of male mice when started at middle age, reports an international team of scientists led...Read more

  • Bayer Russia to hire 800 staff, increase sales to $1.73 bn

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 11 Sep, 2013

    Singapore: Bayer is going to expand its operations in Russia by adding more than 800 staff over the next four years to fuel sales in the country. The firm expects sales of its products in R...Read more

  • Multiple organzations join hands to curb fake drug business

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2012

    Singapore: US Pharmacopeial Convention (USP) is gearing up its efforts to combat fake medicine circulating in the market and has joined hands with 11 new organizations to strengthen its glo...Read more

  • FDA approves Eisai's Fycompa

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2012

    Singapore: Eisai announced that its U.S. subsidiary has received approval from the U.S. Food and Drug Administration (FDA) for the AMPA receptor antagonist Fycompa® (perampanel) as an adj...Read more

  • First-of-its-kind osteoarthritis study done in India

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 21 Sep, 2012

    Bangalore: Signaling relief to over 15 million knee-osteoarthritis patients in India, the world's first study "Osteoarthritis Synvisc One Indian Post Marketing Study" (OASIS) has revealed ...Read more

  • Novartis liver cancer trial with Afinitor flops

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 09 Aug, 2013

    Singapore: Novartis highlighted that the results of a global phase III study showed that Afinitor (everolimus) did not extend overall survival as compared to placebo in patients with locall...Read more

  • Oramed submits pre-IND for exenatide to FDA

    Pharma |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 02 Aug, 2013

    Singapore: Oramed Pharmaceuticals, a developer of oral drug delivery systems, submitted a pre-Investigational New Drug (pre-IND) meeting request to the US FDA for a US-based trial on its or...Read more

  • Alexion to acquire Synageva biopharma for $8.4 bn deal

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 07 May, 2015

    Singapore: Alexion pharmaceuticals recently announced the acquisition of Synageva Biopharma for $8.4 billion. US-based Synageva is a biopharmaceutical company dedicated to discovering, deve...Read more

  • Director resigns at China Nepstar Chain Drugstore

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2012

    Singapore: Mr. Gary Siu Kwan Sik has resigned as an independent director of China Nepstar Chain Drugstore, the largest drugstore chain in China based on the number of directly operated stor...Read more

  • DKSH expands in Hong Kong

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 12 Nov, 2012

    Singapore: DKSH Business Unit Healthcare, a leading partner for healthcare companies seeking to grow their business in Asia, has signed an agreement with Nong's, traditonal chinese medicine...Read more

  • Innovative dual chamber syringe for pharma market

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 05 Jun, 2012

    Singapore: Japan-based Arte and German company ProJect Pharmaceutics are working closely on the development of a new type of dual chamber prefillable syringe for freeze-dried pharmaceutical...Read more

  • Indian FIPB clears pharma FDI proposals worth $536 mn

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 27 Aug, 2012

    New Delhi: The Indian Foreign Investment Promotion Board (FIPB), which is the foreign investment approval authority, has cleared eight of the ten pending proposals of foreign drug firms tha...Read more

  • Arvind sets up $42.37 mn plant top tap US market

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 26 Jun, 2013

    Singapore: Indian pharmaceutical firm, Arvind Remedies has been gearing up to take the US market by storm. The company has invested $42.37 million to set up a new manufacturing facility at ...Read more

  • Agnitio expands in China

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2012

    Singapore: Agnitio, a leader in healthcare sector closed-loop marketing technology, continues to expand its global presence with the opening of regional headquarters in Shanghai and a part...Read more

  • Takeda to acquire LigoCyte Pharma

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2012

    Singapore: Takeda Pharmaceutical Company and LigoCyte Pharmaceuticals, jointly announced that Takeda's wholly-owned subsidiary, Takeda America Holdings and LigoCyte Pharmaceuticals have en...Read more

  • Ranbaxy, Gilead sign licensing agreement

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 03 Aug, 2012

    New Delhi: Ranbaxy Laboratories has entered into an in-licensing agreement with Gilead Sciences to promote access to high-quality, low-cost generic versions of Gilead's HIV medicine emtrici...Read more

  • Universities get $15mn from Teva for CNS R&D

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 25 Jul, 2013

    Singapore: Israel-based Teva is undergoing re-organization in order to mitigate lost revenue from increased competition from copies of its best-selling branded multiple sclerosis drug, Copa...Read more

  • NSF brings Secondary Reference Standards to India

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2012

    Singapore: NSF International, an independent global public health and safety organization which develops standards, and tests and certifies products for the pharmaceutical, dietary suppleme...Read more

Podcast

 

Survey Box

Will stem cell therapy market witness highest growth in Asia by 2020?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls